U.S. Midterm Elections Set to Reshape Congress... Democrats Projected to Dominate Senate and House; Tesla, Apple, Meta, Intel, and Pharma Industry Policy Variables in Focus
If a brake is put on U.S. President Donald Trump's unilateral policy push, the business environment of major technology companies and some pharmaceutical firms could also change. This is because the speed and direction of policies directly tied to corporate performance—such as tariffs, industry supp

If a brake is put on U.S. President Donald Trump's unilateral policy push, the business environment of major technology companies and some pharmaceutical firms could also change. This is because the speed and direction of policies directly tied to corporate performance—such as tariffs, industry support, and deregulation—could shift.
■ Congressional Shift Looks Certain... Impact to Vary by Company The U.S. midterm elections appear all but certain to change the congressional landscape. Democrats are projected to hold the advantage in both the Senate and the House. The impact on individual companies is expected to vary depending on their policy dependence and business structures. Sectors that had counted on deregulation or government support may face greater uncertainty, while for companies burdened by trade conflicts and abrupt policy reversals, the change could actually reduce risk.
■ Tesla, Apple, Meta, Intel... Key Policy Variables by Company For Tesla, the direction of electric vehicle support policies and autonomous driving regulations is the main variable. For Apple, policy changes on tariffs and overseas production networks could affect its cost structure. For Meta, platform competition, privacy protection, and artificial intelligence (AI) regulations are the key areas to watch. Semiconductor companies including Intel will need to monitor support for investment in U.S. production facilities and changes in export controls on China. However, if fostering the semiconductor industry remains a bipartisan policy, a change in political leadership is unlikely to translate directly into reduced support.
■ Pharmaceutical Industry Also Could See Drug Pricing, Tariff, and Approval System Effects Some pharmaceutical companies could also be affected by drug pricing policies, pharmaceutical tariffs, and research and development support and approval systems. The degree to which policy changes affect corporate profitability may vary depending on flagship products and the share of revenue from the U.S. market.
■ Hard to Determine Winners and Losers... Legislative and Executive Actions Need Confirmation At this stage, it is difficult to determine specific corporate winners or losers based on political changes alone. The actual impact will likely be gaugable only after the future congressional composition and specific legislative and executive actions are confirmed.
[This is a scenario based on the possibility of political and policy changes, and does not represent confirmed facts or established forecasts. Actual impacts may vary depending on future policies and individual company circumstances; please check the latest disclosures and official announcements before making investment decisions. Some assistance was provided by AI.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Gold Reclaims $4,000 Level... Direction of Gold Prices in Focus Amid Forecast of Democratic Victory in U.S. Midterm Elections](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F10%2F619342%2F74722a30d8600930%2Fvariants%2Fhero.webp&w=1920&q=75)


![[Featured Stocks] Samsung SDI Soars Over 9%... Secondary Battery Stocks Rally Across the Board Amid Prospects of Democratic Advantage in U.S. Midterm Elections](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F09%2F607242%2F232620384ac9384b%2Fvariants%2Fhero.webp&w=1920&q=75)